bacille Calmette-Guérin

(redirected from bacillus Calmette-Guerin)
Also found in: Medical, Encyclopedia.
Related to bacillus Calmette-Guerin: Bacillus Calmette-Guerin vaccine, Bacillus Calmette-Guérin

bacille Calmette-Guérin (BCG)

n bacilo de Calmette-Guérin (BCG)
Mentioned in ?
References in periodicals archive ?
NASDAQ: EBIO) has completed enrollment in the VISTA Phase 3 registration trial of its lead product candidate, Vicinium, in patients with non-muscle invasive bladder cancer (NMIBC) who have been previously treated with bacillus Calmette-Guerin, the company said.
Babies who were given bacillus Calmette-Guerin, oral polio vaccine were included.
In 1974, the World Health Organization (WHO) established the Expanded Program on Immunization to ensure that all children have access to four routinely recommended vaccines that protect against six diseases (3): bacillus Calmette-Guerin vaccine (to protect against tuberculosis), polio, MCV, and DTP.
A false-positive test may happen if you have been vaccinated recently with the bacillus Calmette-Guerin (BCG) vaccine.
Objective: Immunotherapy with intravesical Bacillus Calmette-Guerin (BCG) application is a gold standard treatment for high risk non-muscle invasive bladder cancer (NMIBC), despite its local and systemic side effects.
TEHRAN (FNA)- Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Guerin to reverse advanced type 1 diabetes demonstrate a potential new mechanism by which the BCG vaccine may restore the proper immune response to the insulin-secreting islet cells of the pancreas.
While intravesical bacillus Calmette-Guerin (BCG) is the recommended therapy for non-muscle-invasive bladder cancer (NMIBC), there is a subset of patients who are refractory to, or relapse on this therapy.
Bacillus Calmette-Guerin (BCG), mitomycin C, epirubicin, and doxorubicin are chemotherapy agents used for intravesical instillation (Shelley, Mason, & Kynaston, 2010).
The use of Bacillus Calmette-Guerin (BCG) is the unique vaccine against tuberculosis being one of the most used in the last 100 years worldwide (17).
The Bacillus Calmette-Guerin (BCG) vaccine is the most commonly used vaccine worldwide to protect infants from tuberculosis (TB).
Bacillus Calmette-Guerin (BCG) vaccination has shown some protective effect against leprosy.
2) Unlike the TST, neither Bacillus Calmette-Guerin vaccine nor infection by non-TB mycobacteria interferes with IGRA results.

Full browser ?